Page last updated: 2024-08-23

tetradecanoylphorbol acetate and iguratimod

tetradecanoylphorbol acetate has been researched along with iguratimod in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoyagi, T; Eguchi, K; Furuichi, I; Hida, A; Kawabe, Y; Kawakami, A; Matsuoka, N; Migita, K; Nakashima, M; Nakashima, T; Origuchi, T; Tsuboi, M; Urayama, S; Yamasaki, S1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and iguratimod

ArticleYear
Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells.
    The Journal of laboratory and clinical medicine, 1999, Volume: 133, Issue:6

    Topics: Adjuvants, Immunologic; Antigen-Presenting Cells; Antigens, CD; Antirheumatic Agents; Benzopyrans; CD58 Antigens; Cell Division; Cells, Cultured; Cytokines; Depression, Chemical; HLA-DR Antigens; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Sulfonamides; Synovial Membrane; T-Lymphocytes; Tetradecanoylphorbol Acetate; Vascular Cell Adhesion Molecule-1

1999